The vasculopathy of Raynaud's phenomenon and scleroderma
Authors:
- Sheila FlavahanSFSheila Flavahan
- Srabani MitraSMSrabani Mitra
- Maqsood A ChotaniMCMaqsood A Chotani
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 29 (2) , 275-291
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Vascular Smooth Muscle Cells of Recipient Origin Mediate Intimal Expansion after Aortic Allotransplantation in MiceThe American Journal of Pathology, 2001
- Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosisThe Journal of Heart and Lung Transplantation, 2000
- Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosisArthritis & Rheumatism, 2000
- Increased Elastin-Degrading Activity and Neointimal Formation in Porcine Aortic Organ CultureArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Response of digital arteries to endothelium dependent and independent vasodilators in patients with Raynaud's phenomenonEuropean Journal of Clinical Investigation, 1995
- Raynaud's phenomenon and scleroderma dysregulated neuroendothelial control of vascular toneArthritis & Rheumatism, 1995
- Endothelin, an endothelial‐dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic actionArthritis & Rheumatism, 1991
- Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferationJournal of Cell Biology, 1988
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971